Voyager Therapeutics (VYGR) Current Assets (2016 - 2025)
Historic Current Assets for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $219.6 million.
- Voyager Therapeutics' Current Assets fell 4119.99% to $219.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.6 million, marking a year-over-year decrease of 4119.99%. This contributed to the annual value of $276.8 million for FY2024, which is 1341.17% down from last year.
- Per Voyager Therapeutics' latest filing, its Current Assets stood at $219.6 million for Q3 2025, which was down 4119.99% from $227.9 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Current Assets registered a high of $409.1 million during Q1 2024, and its lowest value of $124.5 million during Q4 2022.
- In the last 5 years, Voyager Therapeutics' Current Assets had a median value of $227.9 million in 2025 and averaged $235.9 million.
- As far as peak fluctuations go, Voyager Therapeutics' Current Assets plummeted by 4165.68% in 2021, and later soared by 15677.64% in 2023.
- Over the past 5 years, Voyager Therapeutics' Current Assets (Quarter) stood at $136.7 million in 2021, then decreased by 8.92% to $124.5 million in 2022, then soared by 156.78% to $319.7 million in 2023, then fell by 13.41% to $276.8 million in 2024, then dropped by 20.67% to $219.6 million in 2025.
- Its Current Assets was $219.6 million in Q3 2025, compared to $227.9 million in Q2 2025 and $245.2 million in Q1 2025.